.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In August 2026, ufeelu’s mix tilted toward Oil at 51.55% share with year-over-year growth of 36.75% and month-over-month growth of 7.75%, while Vapor Pens held 21.47% share but expanded faster at 119.69% YoY and 12.26% MoM. Topical contributed 24.01% share with 30.92% YoY and 11.34% MoM, and Capsules, though only 2.97% share, accelerated at 180.11% YoY and 14.21% MoM. With an average price decline of 5.02% YoY to $40.59 alongside brand sales growth of 49.55% YoY, the pattern implies volume-led gains concentrated in core Oil while high-growth Vapor Pens and Capsules are widening the base.
The shifts suggest ufeelu is reinforcing a lead posture in Oil—supported by a rank of 1 in Oil in Saskatchewan—yet future upside likely comes from mix diversification as Vapor Pens and Capsules outpace the category anchor by 82.94 percentage points and 143.36 percentage points in YoY growth, respectively. Given Oil’s 51.55% share versus Vapor Pens at 21.47% and Topical at 24.01%, the near-term positioning leans on defending Oil’s scale while reallocating incrementally toward faster-growth formats where MoM gains of 12.26% (Vapor Pens) and 14.21% (Capsules) indicate expanding trial; this balance implies pricing can remain slightly lower YoY without eroding revenue momentum because unit mix is shifting toward higher-velocity items.
Competitive Landscape
ufeelu ranks #5 in ON Oil in August 2026, improving 1 position from #6 year over year and holding steady versus May 2026 at #5; this places it alongside a reshuffled top tier where Mod climbed from #2 to #1 while Redecan slipped from #1 to #2, and where NightNight stayed at #4 as MediPharm Labs remained fixed at #3; given Mod’s 41.9% YoY sales growth against Redecan’s -24.4% and ufeelu’s advancement from #6 to #5, the pattern implies ufeelu’s trajectory is upward but capped by faster-moving leaders, signaling a need to convert rank stability into a push toward the #4 spot.
Notable Products
CBD/CBN/CBG 15:5:1 Rest Moments Capsules 15-Pack (225mg CBD, 75mg CBN, 15mg CBG) posted a -22.4% month-over-month drop to rank 9 while Hi Feel U Dream Live Resin Disposable (1g) slipped -9.5% to rank 10, indicating weakness at the tail as Capsules lose traction relative to inhalables and Oils. In contrast, CBD/CBG/CBC The Feel Stick (500mg CBD, 100mg CBG, 100mg CBC, 30g) rose 11.3% to hold rank 1 and Lavender Acai Tea Live Resin Disposable (1g) gained 18.7% at rank 2, suggesting mix is consolidating around a Topical and a high-velocity Vapor Pen with one product family accounting for four of the top ten spots among Oils. Within Oils, CBD/CBG 3:1 Calm Drops (30ml) advanced 13.2% at rank 4 while CBD/CBG/CBN 2:1:1 Dream Drops (30ml) surged 36.2% at rank 6, but CBD/CBC/CBG 2:1:1 Focus Drops Oils (30ml) fell -8.3% at rank 7, a split that points to sleep and calm use-cases outpacing focus. The pattern implies August 2026 demand is tilting toward restorative formats anchored by a flagship Topical and sleep-oriented Oils, while Capsules contract and discretionary Vapor Pens bifurcate, guiding ufeelu toward deepening sleep/calm formulations and defending the leading Topical SKU rather than broadening Capsules.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
